Fidelity Advisor Biotechnology Fund CYTK Holdings History
Fidelity Advisor Biotechnology Fund's Cytokinetics Inc Holding Summary
As of 2025-04-30, FIDELITY ADVISOR SERIES VII held 6,000.00 shares of Cytokinetics Inc(CYTK), totaling $154,510.00. This investment constitutes 0.01% of their stock portfolio, and FIDELITY ADVISOR SERIES VII now holds 0.01% of the outstanding Cytokinetics Inc(CYTK) stock.
The initial trade took place in 2021Q2. And since then Fidelity Advisor Biotechnology Fund has made 6 purchases of CYTK, at an average price of $34.94, for a total of 2.85 Mil shares. In addition, there have been 7 sales at an average price of $48.51 for 2.84 Mil shares. Based on historical transaction data and CYTK's current price of $37.23, Fidelity Advisor Biotechnology Fund's estimated gain on his CYTK holdings is $38.58 Mil, reflecting a 38.77% gain to date.
Fidelity Advisor Biotechnology Fund CYTK ($37.23) Holding Chart
Fidelity Advisor Biotechnology Fund CYTK ($37.23) Quarterly Buys and Sells
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Avrg. Price |
|---|---|---|---|---|
| Shares Bought | 0 | Average Price $-/Share | ||
| Shares Sold | 0 | Average Price $-/Share | ||
| Current Price $0.00 | Total Estimated Gain 0 % | |||
Top Ranked Articles
- 1
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
